SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius has been caught in a broader neocloud and AI-infrastructure selloff amid concerns about financing costs, debt sustainability and the returns on data-center spending. Traders debate whether NBIS is being unfairly lumped in with more leveraged peers, with some viewing the drop as an oversold buying opportunity and others expecting further downside.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is drawing attention amid a volatile crypto pullback, with traders watching whether it can hold support and reclaim key levels as Bitcoin weakness weighs on the market. The community is split between expecting further downside and viewing the dip as a bear trap that could fuel a short squeeze or rebound.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

ESMO data on Iovances lifileucel programs is driving attention, especially mature frontline melanoma results for lifileucel plus pembrolizumab and early sarcoma findings. Traders see encouraging response durability and potential to expand into new indications, while others note the small cohorts and say larger confirmatory studies will matter more; the melanoma results are also being debated as a mature follow-up of previously reported data.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

A futures rebound after a technology-led selloff has shifted attention to whether the move can hold or will fade as a bull trap or short-covering bounce. Traders are also debating Black Monday anniversary fears, with major tech earnings ahead adding to uncertainty.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSCIs new index-eligibility rules have raised the prospect of Strategy being removed from its indexes, prompting concern about potential passive-fund selling and contributing to the sharp share decline. Traders are divided between expecting more downside from forced selling and viewing the MSCI risk as priced in, with some buying the dip; removal has not been finalized.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

CIFRs steep selloff is being linked to its convertible-note financing and dilution concerns, alongside broader worries about rising costs and returns on AI data-center investments. Traders are split between viewing the decline as an oversold pullback in a long-term AI infrastructure play and fearing that debt, dilution, and execution risks could prolong the weakness.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The prolonged wait for the 80th death event in SELLASs Phase 3 REGAL trial is driving discussion; the companys last disclosed count was 78, and the threshold triggers final analysis. Bulls interpret the delay as possible evidence of longer survival and speculate that results could be tied to ASH, while skeptics say the delay and company silence heighten uncertainty about the trial and its timeline.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras sharp selloff is being discussed in the context of an IPO lockup release that made more shares eligible for sale, alongside a broader pullback in AI and semiconductor stocks. Traders debate whether added share supply, a high valuation and concerns about growth and OpenAI exposure could prolong the decline, while others see the drop as an oversold buying opportunity and remain bullish on Cerebras AI-inference technology.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Fords upcoming quarterly results are drawing attention after weaker U.S. sales and a supplier disruption that curtailed F-150 production, alongside a sharp drop in EV sales. Traders are split between expecting continued pressure and buying the dip, with some pointing to resilient truck demand and the possibility of a rebound.

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

BNBs price action and repeated technical setups dominate discussion, with traders tracking consolidation, support and resistance after a rebound. Sentiment is split between hopes for further upside and warnings that the bounce may fade or lead to another pullback.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

YD Bio (NASDAQ:YDES) Shares Up 2.8% - Here's Why

YD Bio (NASDAQ:YDES) Shares Up 2.8% - Should You Buy...

YD Bio (NASDAQ:YDES) Shares Gap Up - What's Next?

YD Bio (NASDAQ:YDES) Shares Gap Up - Here's What Happened...

YD Bio (NASDAQ:YDES) Trading Down 3.5% - Here's What Happened

YD Bio (NASDAQ:YDES) Trading Down 3.5% - Time to Sell...

YD Bio (NASDAQ:YDES) Trading 12.5% Higher - Here's Why

YD Bio (NASDAQ:YDES) Trading 12.5% Higher - Here's Why...

Apogee Therapeutics, Tower Semiconductor, Norwegian Cruise Line And Other Big Stocks Moving Higher On Thursday

Stocks fall, Nasdaq drops 200 points. Apogee Therapeutics (APGE) rises 19.4% on positive trial data. Satellogic (SATL), YD Bio (YDES), AXT Inc (AXTI) also see gains.read more...

YD Bio (NASDAQ:YDES) Sets New 52-Week Low - Here's What Happened

YD Bio (NASDAQ:YDES) Hits New 52-Week Low - Should You Sell...

YD Bio (NASDAQ:YDES) Stock Price Down 5.6% - Here's Why

YD Bio (NASDAQ:YDES) Trading Down 5.6% - Here's Why...

YD Bio (NASDAQ:YDES) Trading 7.9% Higher - Still a Buy?

YD Bio (NASDAQ:YDES) Stock Price Up 7.9% - What's Next...

YD Bio (NASDAQ:YDES) Shares Gap Up - Time to Buy?

YD Bio (NASDAQ:YDES) Shares Gap Up - Time to Buy...

YD Bio (NASDAQ:YDES) Stock Price Down 9.1% - Here's Why

YD Bio (NASDAQ:YDES) Stock Price Down 9.1% - Here's What Happened...

YD Bio Ltd. is a biotechnology company building an integrated healthcare platform across regulated diagnostics, clinical services, and commercial healthcare markets. It operates DNA methylation–based oncology testing programs under an LDT-first strategy and provides compliant life science distribution and clinical trial supply chain services to pharmaceutical and biotechnology partners. The company’s offerings include cancer detection products, regenerative ophthalmology solutions, and exosome-based technologies. YD Bio was founded on February 6, 2024 and is headquartered in Taipei, Taiwan.

YD Bio Ltd.

YD Bio Stock Rises On Entry Into US Eye Care Segment

Equity

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$5.92
Prev Close	$6.74
Open	$6.67
Dividend Yield	0.00%
50-Day Moving Average	$4.64
Beta	0.07
Avg. Volume	682,625.03
PE Ratio	-5.99

52-Week High	$22.00
52-Week Low	$1.70
Market Capitalization	$419.39M
EPS (Annual)	-$0.1246
Price to Book	93.75
Revenue Per Employee	$39,787.80

Feed

News

Sentiment

Fundamentals

Info

YDES Fundamentals